Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, April 27, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
KemPharm Submits KP415 NDA to USFDA for the Treatment of attention deficit hyperactivity disorder (ADHD)
admin
-
March 3, 2020
0
Latest Pharma-News
FDA grants Breakthrough Therapy Designation for Roche’s Esbriet (pirfenidone) in unclassifiable interstitial lung disease
admin
-
March 3, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to the respirators, including N95s, for the health care personnel
admin
-
March 3, 2020
0
Latest Pharma-News
FDA allows labs margin in testing for coronavirus
admin
-
March 2, 2020
0
Latest Pharma-News
USFDA Approves First Generic of Daraprim
admin
-
March 2, 2020
0
Latest Pharma-News
USFDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for the treatment of HER2-positive breast cancer
admin
-
February 28, 2020
0
Latest Pharma-News
Sanofi to create new industry-leading European company to provide active pharmaceutical ingredients
admin
-
February 28, 2020
0
Latest Pharma-News
AstraZeneca divests global rights to Movantik (naloxegol)
admin
-
February 27, 2020
0
Latest Pharma-News
Y-mAbs Announces Positive Pre-Biologics License Application Meeting with FDA for Omburtamab
admin
-
February 27, 2020
0
Latest Pharma-News
NIH clinical trial of remdesivir to treat coronavirus disease 2019 (COVID-19) begins
admin
-
February 27, 2020
0
Latest Pharma-News
Novartis announces FDA and EMA filing acceptance of ofatumumab (OMB157), a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)
admin
-
February 27, 2020
0
Latest Pharma-News
Novartis receives EC Approval for Beovu®(brolucizumab), a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide
admin
-
February 20, 2020
0
1
...
126
127
128
...
144
Page 127 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024